Search

Invest with us

Invest with us in new vaccine R&D factory and become Shareholder

  • S-Pharma - Investment in Biopharmaceutical R&D factory for vaccine and medicines. 
  • Discovering, developing and providing different branche of vaccines and medicines. 
  • Production Plan: 
  • 300 million vaccines/month (1.2 billion vaccines yearly)
  • Investment in cooperation with Grafin Invest Project
  • Investment process for S-Pharma London in cooperation and supervises with Grafin Invest Project.
  • The development is due to complete in Q1 2021/Q3 2021

S-Pharma New Vaccine R&D Factory - become shareholder

Brand new Biopharmaceutical R&D (research & development) factory with vaccine and medicines factory.
  • Type of business: Biopharmaceutical R&D (research & development) factory with vaccine and medicines factory. 
  • The development is due to complete in Q1 2021. or Q3 2021 
  • Location of Investment: European Union (EU) 
  • Full Investment (Capital cost): 246.000.000 € based on one R&D Factory for Vaccine and medicines. 
  • Holdings: Total of 24600 Share at 10.000 €. 
  • Min. investment 10.000 € for One share and One Voting Rights. 
  • Max. Investment 61..500.000 € for 25% Ownership and 6150 Share and Voting Rights.
  • One Share are One voting Rights.
  • Vaccine factory stocks give additional income, or you can sell it at a higher price per share and earn from it as well. 
  • Our project report also maintains that will grow by over next five years with Up to 24% return pro year. 
  • Management team with record of success.
Ownership  of shares (until now): 
  • S-Pharma U.K. own 6150 share (25% ownership) of New Vaccine Biopharmaceutical Factory.
  • Live Insurance Company U.K own 2460 share (10% ownership) 
  • Private Investor own 2977 share (12,1%) (Investor from: Suisse, UK, USA, Russia, Germany, UAE, SA, China, Italy, Bahrain, Poland, Kuwait, Croatia, Spain, Israel, Netherland, Sweden, Norvege, Danemark and Island,
  • Every Investor have "Memorandum and Articles of Association" and shareholder certify.
  • One Share are One voting Rights.
Project number: 888 048 

  • Investment process for S-Pharma London controls and supervises Grafin Invest

Why Invest with us?

S-Pharma, a United Kingdom company for the manufacturing and sale of pharmaceutical products. Fully operational Pharmaceutical Production Facilities with all standards/certificates. Our project report also maintains that will grow by over next five years with Up to 24% return pro year.
S-Pharma - Investment in New Advanced Research and Development (SARD) Biopharmaceutical factory, for vaccine and medicines. and S-Pharma entered a public-private partnership to establish our Center for Innovation in Advanced Development and Manufacturing. 
Discovering, developing and providing different branche of medicines and vaccines. The SARD facilitates advanced development of chemical, biological, radiological, and nuclear (CBRN) medical countermeasures and ensures domestic manufacturing surge capacity.
S-Pharma Inc. are member of Sentange Group London U.K.
  • Vaccines are one of the greatest public health success stories in history. 
  • S-Pharma and its legacy companies and our partners have been working to discover and develop vaccines. Our vaccines have helped prevent a number of diseases, including ones never thought preventable. Today, we remain dedicated to the complex business of researching and producing vaccines. 
  • Now S-Pharma and our partners have been working to discover and develop coronavirus vaccines.
  • BCG Vaccine: up to 10 mill/Year 
  • VARICELLA VACCINE: up to 10 mill/Year 
  • MMR VACCINE: up to 10 mill/Year 
  • DTP VACCINE: up to 10 mill/Year 
  • INFLUENCA VACCINE: up to 10 mill/Year 
  • PNEUMO VACCINE: up to 10 mill/Year 
  • ROTA VACCINE: up to 10 mill/Year 
  • EVAC (Ebola Vaccine): up to 10 mill/Year 
  • CORONAVIRUS VACCINE (in R&D process)
MEDICINES: 
Consumer & Prescription medicine
  • CHC – Consumer Healthcare
  • Rx – Prescription medicine

Invest with us

Invest in new Biopharmaceutical R&D (research & development) factory with vaccine and medicines factory. Investment process for S-Pharma London controls and supervises Grafin Invest Project